It was concluded that the metformin group had a lower risk of primary cesarean section and congenital malformations while the insulin group and the group that switched to insulin had similar pregnancy outcomes between them that included risk of cesarean section, pregnancy-induced hypertension, and preterm birth [38]. This evidence concerns the gene INS and Hypertension.